3 unknown, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow this condition Literature Review of Chronic Myeloid Leukemia in Myeloid Blast Crisis trials Research Report on Chronic Myeloid Leukemia in Myeloid Blast Crisis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) Orca-Q - Acute Myeloid Leukemia, Acute Lymphoid Leukemia | Phase 1 / Phase 2 | Recruiting | University of Florida | 40 | 2022-08-16 | 2026-09-01 |
| Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CML based decitabine and olverembatinib（HQP1351)chemotherapy - Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 40 | 2021-12-01 | 2022-12-08 |
| European CML Blast Crisis Register Chronic Myeloid Leukemia in Myeloid Blast Crisis | Unknown | University of Jena | 250 | 2018-10-25 | 2023-05-10 | |
| Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML Nilotinib+AD induction - Chronic Myeloid Leukemia in Myeloid Blast Crisis, Untreated Adult Acute Myeloid Leukemia | Phase 2 | Unknown | Ulsan University Hospital | 46 | 2012-09-01 | 2016-05-11 |
Leukemia, Myeloid, Accelerated Phase (2) · Leukemia, Myeloid, Acute (2) · Disease (1) · Hematologic Neoplasms (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Bone Marrow Diseases (3) · Chronic Disease (3) · Disease Attributes (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Leukemia (3) · Leukemia, Myeloid (3) · Myeloproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
nilotinib (1)
Nanfang Hospital, Southern Medical University (1) · Ulsan University Hospital (1) · University of Florida (1) · University of Jena (1)
China (1) · Czechia (1) · Germany (1) · Russia (1) · South Korea (1) · Ukraine (1) · United States (1)
Annamaria Brioli, PhD MD (1) · Hawk Kim, M.D., Ph.D. (1) · Jordan Milner, MD (1)